Ophthalmology Doctors in Woodbury, NY Accepting Medicare

5 Ophthalmology doctors found. Showing 1 - 5

Lawrence I Ross, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 225 Froehlich Farm Blvd, Woodbury, NY 11797 Phone: 516-364-5400    Fax: 516-677-3653

Habeeb Ahmad, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 225 Froehlich Farm Blvd, Woodbury, NY 11797 Phone: 516-364-5400    Fax: 516-677-3656

Dr. Karla Annette Blakes, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 225 Froehlich Farm Blvd, Woodbury, NY 11797 Phone: 516-364-5400    Fax: 516-677-3656

Dr. David Allen Schlessinger, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 75 Froehlich Farm Blvd, Woodbury, NY 11797 Phone: 516-496-2122    Fax: 516-496-2201

Dr. Carol J Lin, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 225 Froehlich Farm Blvd, Woodbury, NY 11797 Phone: 516-364-5400    Fax: 516-941-4889

News Archive

Consumer reports details the screening tests that may be unneccesary

Consumer Reports/The Washington Post: "Many Americans - and their doctors - seem to think that better health means more health care, including as many screening tests as possible. But many researchers are questioning that notion, saying that some common screening tests are unproven and can not only waste your time and money but also cause more harm than good."

Women at high risk of postpartum psychosis need very careful care, says new review

There are clear risk factors for postpartum psychosis that all women should be asked about antenatally to ensure early recognition and prompt treatment of the condition, says a new review published today (12 July) in The Obstetrician & Gynaecologist.

Boehringer Ingelheim's new afatinib-cetuximab phase Ib data in NSCLC presented at ASCO 2011

Boehringer Ingelheim Pharmaceuticals, Inc. will present new phase Ib data at the 2011 American Society of Clinical Oncology annual meeting in Chicago that indicates combining its investigational therapy afatinib with cetuximab at the maximum tested dose controlled disease in all (n=22) treated epidermal growth factor receptor (EGFR)-mutation positive patients with non-small cell lung cancer who developed acquired resistance to treatment with a reversible EGFR tyrosine kinase inhibitor.

RUB experiment: Consequences of light stimulation

Whenever we are doing something, one of our brain hemispheres is more active than the other one. However, some tasks are only solvable with both sides working together. PD Dr. Martina Manns and Juliane R-mling of the Ruhr-Universit-t Bochum are investigating, how such specializations and co-operations arise.

Read more Medical News

› Verified 3 days ago